- Home
- ALGS vs VTVT Comparison
ALGS vs VTVT Comparison
Compare ALGS & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- VTVT
- Stock Information
- Founded
- ALGS 2018
- VTVT 2015
- Country
- ALGS United States
- VTVT United States
- Employees
- ALGS N/A
- VTVT N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- ALGS Health Care
- VTVT Health Care
- Exchange
- ALGS Nasdaq
- VTVT Nasdaq
- Market Cap
- ALGS 53.0M
- VTVT 47.9M
- IPO Year
- ALGS 2020
- VTVT 2015
- Fundamental
- Price
- ALGS $10.15
- VTVT $21.51
- Analyst Decision
- ALGS Strong Buy
- VTVT Strong Buy
- Analyst Count
- ALGS 2
- VTVT 2
- Target Price
- ALGS $60.00
- VTVT $35.50
- AVG Volume (30 Days)
- ALGS 71.0K
- VTVT 5.9K
- Earning Date
- ALGS 11-05-2025
- VTVT 11-11-2025
- Dividend Yield
- ALGS N/A
- VTVT N/A
- EPS Growth
- ALGS N/A
- VTVT N/A
- EPS
- ALGS N/A
- VTVT N/A
- Revenue
- ALGS $3,174,000.00
- VTVT $17,000.00
- Revenue This Year
- ALGS N/A
- VTVT N/A
- Revenue Next Year
- ALGS N/A
- VTVT N/A
- P/E Ratio
- ALGS N/A
- VTVT N/A
- Revenue Growth
- ALGS N/A
- VTVT N/A
- 52 Week Low
- ALGS $3.76
- VTVT $12.62
- 52 Week High
- ALGS $46.80
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- ALGS 51.19
- VTVT 49.56
- Support Level
- ALGS $9.61
- VTVT $22.42
- Resistance Level
- ALGS $10.64
- VTVT $22.66
- Average True Range (ATR)
- ALGS 0.70
- VTVT 1.16
- MACD
- ALGS -0.02
- VTVT -0.34
- Stochastic Oscillator
- ALGS 43.54
- VTVT 15.20
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.